Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
25.3.2021
0:00
17:39
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
Flere episoder fra "JAMA Oncology Author Interviews"
Gå ikke glip af nogen episoder af “JAMA Oncology Author Interviews” - abonnér på podcasten med gratisapp GetPodcast.